Connection

Jérôme de Sèze to Vascular Endothelial Growth Factor A

This is a "connection" page, showing publications Jérôme de Sèze has written about Vascular Endothelial Growth Factor A.
  1. Matrix metalloproteinase 9 is decreased in natalizumab-treated multiple sclerosis patients at risk for progressive multifocal leukoencephalopathy. Ann Neurol. 2017 Aug; 82(2):186-195.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.